These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 9116607)
1. The alkyl-lysophospholipid, ET-18-OCH3 synergistically enhances the Merocyanine 540-mediated photoinactivation of leukemia cells: implications for the extracorporeal purging of autologous hematopoietic stem cells. Yamazaki T; Sieber F Bone Marrow Transplant; 1997 Jan; 19(2):113-9. PubMed ID: 9116607 [TBL] [Abstract][Full Text] [Related]
2. Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts. Yamazaki T; Sato Y; Sieber F Exp Hematol; 1997 Jul; 25(7):629-37. PubMed ID: 9216739 [TBL] [Abstract][Full Text] [Related]
3. Anti-tumor effect of Merocyanine 540-mediated photochemotherapy combined with Edelfosine: potential implications for the ex vivo purging of hematopoietic stem cell grafts from breast cancer patients. Anderson GS; Miyagi K; Sampson RW; Sieber F J Photochem Photobiol B; 2002 Nov; 68(2-3):101-8. PubMed ID: 12468204 [TBL] [Abstract][Full Text] [Related]
5. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation. Dietzfelbinger HF; Kühn D; Zafferani M; Hanauske AR; Rastetter JW; Berdel WE Cancer Res; 1993 Aug; 53(16):3747-51. PubMed ID: 8339286 [TBL] [Abstract][Full Text] [Related]
6. Effect of hypothermia on the merocyanine 540-mediated purging of hematopoietic cells. Yamazaki T; Sieber F J Hematother; 1997 Feb; 6(1):31-9. PubMed ID: 9112216 [TBL] [Abstract][Full Text] [Related]
7. Preferential inactivation of paediatric solid tumour cells by sequential exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: implications for the ex vivo purging of autologous haematopoietic stem cell grafts. Anderson GS; Tsujino I; Miyagi K; Sampson R; Sieber F J Photochem Photobiol B; 2003 Feb; 69(2):87-95. PubMed ID: 12633981 [TBL] [Abstract][Full Text] [Related]
8. Differential cytotoxicity of an ether lipid on lymphoma and bone marrow cells and its role in purging malignant lymphoid cells from remission bone marrow contaminated with tumor cells. Dietzfelbinger HF; Lang A; Oberberg D; Rastetter JW; Berdel WE Exp Hematol; 1992 Feb; 20(2):178-83. PubMed ID: 1544386 [TBL] [Abstract][Full Text] [Related]
9. Photodamaging effects of merocyanine 540 on neutrophils and HL-60 cells. Smith OM; Traul DL; Sieber F Exp Hematol; 1992 Dec; 20(11):1278-84. PubMed ID: 1337324 [TBL] [Abstract][Full Text] [Related]
10. Potentiation of merocyanine 540-mediated photodynamic therapy by salicylate and related drugs. Traul DL; Anderson GS; Bilitz JM; Krieg M; Sieber F Photochem Photobiol; 1995 Oct; 62(4):790-9. PubMed ID: 7480156 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of merocyanine 540-mediated phototherapy by salicylate. Anderson MS; Kalyanaraman B; Feix JB Cancer Res; 1993 Feb; 53(4):806-9. PubMed ID: 8381329 [TBL] [Abstract][Full Text] [Related]
12. Postirradiation hyperthermia selectively potentiates the merocyanine 540-sensitized photoinactivation of small cell lung cancer cells. Tsujino I; Anderson GS; Sieber F Photochem Photobiol; 2001 Feb; 73(2):191-8. PubMed ID: 11272734 [TBL] [Abstract][Full Text] [Related]
13. Merocyanine 540-sensitized photoinactivation of high-grade non-Hodgkin's lymphoma cells: potential application in autologous BMT. Itoh T; Messner HA; Jamal N; Tweeddale M; Sieber F Bone Marrow Transplant; 1993 Sep; 12(3):191-6. PubMed ID: 8241975 [TBL] [Abstract][Full Text] [Related]
14. Potentiation of the antitumor effect of Merocyanine 540-mediated photodynamic therapy by amifostine and amphotericin B. Tsujino I; Miyagi K; Sampson RW; Sieber F Photochem Photobiol; 2006; 82(2):458-65. PubMed ID: 16613499 [TBL] [Abstract][Full Text] [Related]
15. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines. Shoji M; Fukuhara T; Winton EF; Berdel WE; Vogler WR Exp Hematol; 1994 Jan; 22(1):13-8. PubMed ID: 8282054 [TBL] [Abstract][Full Text] [Related]
16. Photochemical purging of autologous bone marrow grafts: assessment of damage to stem cells and the microenvironment in long-term marrow cultures. Kubo Y; Sieber F Bone Marrow Transplant; 1997 Jul; 20(1):27-31. PubMed ID: 9232252 [TBL] [Abstract][Full Text] [Related]
17. Selenoperoxidase-mediated cytoprotection against merocyanine 540-sensitized photoperoxidation and photokilling of leukemia cells. Lin F; Geiger PG; Girotti AW Cancer Res; 1992 Oct; 52(19):5282-90. PubMed ID: 1394132 [TBL] [Abstract][Full Text] [Related]
18. The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservation. Verdonck LF; Heesbeen EC; van Heugten HG; Staal GE; Rijksen G Bone Marrow Transplant; 1992 Apr; 9(4):241-5. PubMed ID: 1600412 [TBL] [Abstract][Full Text] [Related]
19. [Merocyanine 540-mediated photodynamic therapy inhibits P-glycoprotein (P-gp) activity in adriamycin-resistant K562 cells]. Sato Y; Yamazaki T; Yasukawa K; Kaneita Y; Mochimaru J; Hanai M; Irie T; Kura Y; Sawada U; Horie T Gan To Kagaku Ryoho; 1999 Dec; 26(14):2195-200. PubMed ID: 10635304 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of merocyanine 540-mediated photodynamic therapy on cellular immune functions: A role in the prophylaxis of graft-versus-host disease? Traul DL; Sieber F J Photochem Photobiol B; 2015 Dec; 153():153-63. PubMed ID: 26410039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]